Current Perspectives on Pathobiology of the Ductus Arteriosus
- PMID: 23519783
- PMCID: PMC3601484
- DOI: 10.4172/2155-9880.S8-001
Current Perspectives on Pathobiology of the Ductus Arteriosus
Abstract
The ductus arteriosus (DA) shunts blood away from the lungs during fetal life, but at birth this shunt is no longer needed and the vessel rapidly constricts. Postnatal persistence of the DA, patent ductus arteriosus (PDA), is predominantly a detrimental condition for preterm infants but is simultaneously a condition required to maintain systemic blood flow for infants born with certain severe congenital heart defects. Although PDA in preterm infants is associated with significant morbidities, there is controversy regarding whether PDA is truly causative. Despite advances in our understanding of the pathobiology of PDA, the optimal treatment strategy for PDA in preterm infants is unclear. Here we review recent studies that have continued to elucidate the fundamental mechanisms of DA development and pathogenesis.
Keywords: Patent ductus arteriosus; Vascular development.
References
-
- Stoller JZ, Epstein JA. Cardiac neural crest. Seminars in cell & developmental biology. 2005;16:704–715. - PubMed
-
- Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Current opinion in pediatrics. 2004;16:146–151. - PubMed
-
- Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30:241–252. - PubMed
-
- Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125:1020–1030. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Medical